Last update 23 Jan 2025

Shanghai Tangji Biotechnology Co., Ltd.

Private Company|
2022|
Shanghai Shi, China

Overview

Tags

Respiratory Diseases
Skin and Musculoskeletal Diseases
Infectious Diseases
Chemical drugs

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Infectious Diseases1
Top 5 Drug TypeCount
Chemical drugs1

Related

1
Drugs associated with Shanghai Tangji Biotechnology Co., Ltd.
SM-V-61
Target-
Mechanism-
Active Org.
Shanghai Tangji Biotechnology Co., Ltd. [+1]
Originator Org.
Shanghai Tangji Biotechnology Co., Ltd.
Active Indication
Gram-Positive Bacterial Infections [+5]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Shanghai Tangji Biotechnology Co., Ltd.
CTR20244032
/ RecruitingPhase 1
一项在中国健康受试者中随机、双盲、安慰剂对照、剂量递增、单次和多次静脉输注，评价注射用SM-V-61的安全性、耐受性及药代动力学特征的 I 期临床研究
[Translation] A randomized, double-blind, placebo-controlled, dose-escalating, single and multiple intravenous infusion Phase I clinical study in healthy Chinese subjects to evaluate the safety, tolerability and pharmacokinetic characteristics of SM-V-61 for injection
100 Clinical Results associated with Shanghai Tangji Biotechnology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Shanghai Tangji Biotechnology Co., Ltd.
Login to view more data
100 Deals associated with Shanghai Tangji Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Tangji Biotechnology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
SM-V-61
Skin and skin structure infections
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free